[ad_1]
Write a paper, answering the following questions:
What are your recommendations regarding the manufacturing of CRP-1 for Phase 1 and Phase 2 clinical trials? Please compare all the options open to the company using quantitative and qualitative details from the case study (do not overlook the exhibits) and evaluate their advantages and disadvantages before making your recommendation.
What are your recommendations regarding manufacturing for Phase 3 clinical trials and commercialization? Please compare all the options open to the company using quantitative and qualitative details from the case study (do not overlook the exhibits) and evaluate their advantages and disadvantages before making your recommendation. Please make sure your choice is consistent with your recommendation for Phases 1 & 2.
How would you justify your recommendations to would-be investors in the company? Identify the details from the case that investors are most likely to be interested in. Calculating the decision tree and NPV of the different options for the company is outside the scope of this course, however please include a comparison of risks and returns that may persuade a would-be investor.
What is your recommendation(s) regarding Nucleon’s long-term manufacturing strategy? What should the company look like in 10 years for the time of the case study? Describe the long-term strategies the company could pursue, and describe how these strategies relate to decisions about CRP-1.
[ad_2]
Source link
